BackgroundBronchobiliary fistula and hepatic artery pseudoaneurysm are rare complications of hepatic trauma. There are isolated case reports for both pseudoaneurysm and bronchobiliary fistula following hepatic trauma but there aren’t reports of both conditions developing in a single patient.Case presentationThis case describes an 18 year old hindu male who developed right hepatic artery pseudoaneurysm and bronchobiliary fistula following blunt abdominal trauma. Patient was managed with exploratory laparotomy followed by coil embolization and Endoscopic retrograde cholangiopancreatography stenting respectively.ConclusionRare complications of liver trauma include pseudoaneurysm and bronchobiliary fistula. These complications can rarely co- exist in a single patient.
We present a rare case of a 45‐year‐old man with abdominal pain and features suggestive of intestinal obstruction. The CT scan of the abdomen demonstrated a large mesenteric mass involving the distal segment of jejunum. Surgical excision of the lesion and histopathological examination revealed the diagnosis of cavernous hemangioma.
Background:The gold standard of quick and definitive treatment of Abdominal compartment syndrome (ACS) is surgical decompression by opening the abdomen and leaving it open until intra-abdominal pressure decreases. Temporary abdominal closure techniques are used to postpone definite closure until predisposing factors causing pathologic elevation of intra-abdominal pressure are resolved.This study aim to analyze feasibility of Bogota Bag placement as a way of temporary abdominal closure.
Methods:Cases admitted in the period of eight years that were diagnosed to have or at risk to develop ACS and managed with 'Bogota Bag', irrespective of primary diagnosis were reviewed retrospectively. Cause of ACS, reasons to place Bogota bag, its complications and final outcome in terms of mortality related or not related with Bogota Bag placement were assessed.
Results:Total of ten patients had placement of Bogota Bag in the period of eight years. Laparotomy for bowel perforation with peritonitis was the most common primary condition contributing to ACS. Bogota bag was placed in two cases after emergency decompression as a therapeutic measure whereas others were done as prophylactic measure. There were two mortalities (20%) which were not directly related to abdominal compartment syndrome.
Conclusions:Abdomen closure with Bogota Bag for patients with ACS or likely to develop ACS is a feasible technique with minimal procedure related morbidities.
Abdominal sacro-colpopexy (ASC) is a commonly performed procedure for the surgical treatment of pelvic organ prolapse (POP). Surgeons favor this technique because of its well-established success rates ranging from 78-100% and durability, which is attributed to reinforcement of native tissues with a graft. Despite recognition of the risk of erosion, synthetic grafts have been preferred over autologous grafts for abdominal sacro-colpopexy because they are durable, avoid the morbidity and operative time of harvesting fascia, are readily available and are relatively inexpensive. Ideally, these benefits should outweigh the possibility of erosion, which is a unique complication of using a graft.We present here a unique case of mesh erosion into bowel after sacro-colpopexy who presented with sigmoido-vaginal fistula.
We present a rare case of 45-year-old man with complaints of abdominal
pain and features suggestive of intestinal obstruction. CT scan of the
abdomen demonstrated a large mesenteric mass in the pelvic region
involving the distal segment of jejunum. Surgical excision of the lesion
and histo-pathological examination confirmed cavernous hemangioma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.